Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2013; 19(39): 6523-6528
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6523
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6523
Patients | Cytokines | Chemokines |
GERD | IL-6[8,23], and IL-8[8-11,23,25,29], IL-1β[23,28,32,38], INF-γ[8], TNF-α[20,38] | |
ERD | IL-6[32,37], IL-8[8-11,25,28], IL-1β[28,32,37,38] | PAF[11,36,37], MCP-1[9-11,36,38], RANTES[9,36], MIP1-α[11,36,38], Eotaxin-1, Eotaxin-2 and Eotaxin-3[11,36], CINC-2α[38], and ICAM-1[38] |
NERD | IL-8[10,25,28], IL-1β[28] | |
Barrett's esophagus | IL-8[8], IL-4[8], TNF-α[34], IL-6[34], IL-8[35] |
- Citation: Altomare A, Guarino MPL, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol 2013; 19(39): 6523-6528
- URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6523.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6523